Tag:

hmpv

Health

First HMPV case detected in Maharashtra this year recovers

by Chief Editor
written by Chief Editor

Understanding the Rise of Human Metapneumovirus (HMPV)

Respiratory health monitoring is entering a new phase as health officials keep a closer eye on Human Metapneumovirus (HMPV). Even as often mistaken for a common cold, this virus represents a significant part of the respiratory landscape, particularly for vulnerable populations.

From Instagram — related to Human, Metapneumovirus

HMPV is a respiratory pathogen first identified in the Netherlands in 2001 and detected in India in 2003. It belongs to the Paramyxoviridae family, placing it in the same category as other well-known respiratory threats like the parainfluenza virus and respiratory syncytial virus (RSV).

Did you know? HMPV primarily targets the respiratory tract and can cause a spectrum of illnesses ranging from mild, cold-like symptoms to severe conditions such as bronchitis and pneumonia.

The Shift Toward Precision Diagnostics

One of the most critical trends in managing respiratory infections is the move away from general diagnoses toward precise molecular testing. In recent cases, patients presenting with influenza-like illness (ILI) were initially suspected of having the flu, only to be confirmed as HMPV positive through polymerase chain reaction (PCR) tests.

The use of PCR testing allows healthcare providers to differentiate between various respiratory viruses, ensuring that patients receive the most appropriate care. For example, recent medical interventions at facilities like AIIMS Nagpur have demonstrated the effectiveness of specialized care in treating infants infected with the virus.

The Role of Integrated Surveillance

To prevent sporadic cases from becoming outbreaks, health departments are leveraging networks like the Integrated Disease Surveillance Programme (IDSP). By monitoring surges in severe acute respiratory illness (SARI) and ILI, officials can identify patterns and respond quickly to new infections.

Two More Children Detected With HMPV In Nagpur, Maharashtra; Total Cases In India Increase To 7
Pro Tip: If a child or elderly family member exhibits persistent respiratory symptoms, seek a professional medical evaluation. Early PCR testing can help identify the specific virus and guide the treatment plan.

Managing High-Risk Populations

While HMPV can infect individuals across all age groups, the trend in clinical data shows that certain demographics are at a much higher risk. The virus poses the greatest threat to:

  • Young children: Including infants who may require hospitalization for respiratory support.
  • Older adults: Whose immune systems may be less resilient.
  • Immunocompromised individuals: Those with weakened immune systems are more susceptible to severe complications.

Current health strategies emphasize the immediate identification of close contacts when a case is detected. In recent instances, family members of infected patients have been screened to ensure there is no immediate household spread, a tactic that helps contain the virus effectively.

Global Trends and Future Preparedness

The approach to HMPV is increasingly influenced by global health events. Reports of HMPV outbreaks in China have prompted various Indian state governments—including Maharashtra, Karnataka, and Delhi—to ramp up monitoring and issue preparedness guidelines.

Interestingly, some of these guidelines mirror the protocols used during the Covid-19 pandemic. This indicates a long-term trend where governments are adopting a “pandemic-ready” posture for all significant respiratory pathogens, rather than reacting only after an outbreak occurs.

From the first reported case in Bengaluru in early 2025 to subsequent detections in other states, the trend is clear: increased vigilance and standardized guidelines are becoming the norm for respiratory virus management in India.

Frequently Asked Questions

What are the symptoms of HMPV?
Symptoms are often similar to the common cold, including sore throat, running nose, body ache, headache, and fever. In severe cases, it can lead to pneumonia or bronchitis.

Is HMPV the same as the flu?
No. While it presents as an influenza-like illness (ILI), HMPV is a different respiratory virus from the Paramyxoviridae family.

How is HMPV spread?
The virus spreads through infectious respiratory particles. This occurs when a person shares a closed space with an infected individual or touches contaminated surfaces (like doorknobs) and then touches their eyes, nose, or mouth.

Is there an HMPV outbreak currently?
While there have been reports of outbreaks in China, health officials in states like Maharashtra have stated that cases remain sporadic and there is currently no outbreak in the state.

Stay Informed on Public Health

Want to keep up with the latest health trends and surveillance updates? Subscribe to our newsletter or explore more articles on respiratory health.

Do you have questions about respiratory wellness? Let us know in the comments below!

0 comments
0 FacebookTwitterPinterestEmail
Health

A virus that isn’t COVID or the flu is pummeling Northern California

by Chief Editor
written by Chief Editor

The “Barking Cough” is Back: What You Necessitate to Understand About HMPV

A respiratory virus, human metapneumovirus (HMPV), is currently circulating at high levels in several areas of California, including San Francisco, Marin, Vallejo, Napa, Novato, Santa Rosa, Sacramento and Davis. Wastewater surveillance data from WastewaterSCAN indicates a significant presence of the virus, prompting health officials to raise awareness.

What is HMPV and Why is it Surging Now?

HMPV is a common respiratory virus that typically causes mild, cold-like symptoms such as cough, fever, and congestion. However, it can sometimes lead to more serious conditions like bronchiolitis and croup, particularly in young children. Croup is characterized by a distinctive “barking” cough, resembling a seal’s bark, according to the Mayo Clinic.

Dr. Monica Gandhi, an infectious disease specialist at UC San Francisco, explains that the decrease in COVID-19 cases this season has created an opportunity for other viruses, like influenza and HMPV, to spread more easily. “These illnesses compete with each other,” she stated. “When we had big COVID surges, we saw really low rates of other common cold viruses.”

National Trends and Regional Hotspots

The upward trend of HMPV isn’t limited to California. Data from the Centers for Disease Control and Prevention (CDC) shows increasing HMPV concentrations across the United States. Currently, the Midwest and Northeast are experiencing the highest rates of the virus, according to WastewaterSCAN data.

As an RNA virus, HMPV thrives in colder environments. Increased indoor crowding during colder months facilitates its rapid spread. However, California’s milder weather and emphasis on ventilation may offer some protection.

Prevention and Treatment

The CDC recommends simple preventative measures to limit the spread of HMPV: stay home when sick, practice frequent handwashing, and regularly clean surfaces. Currently, there are no specific treatments or vaccines for HMPV. Most individuals recover with rest, fluids, and supportive care.

Pro Tip: Frequent handwashing and disinfecting commonly touched surfaces are key to preventing the spread of respiratory viruses like HMPV.

What Does the Future Hold?

The resurgence of HMPV highlights the complex interplay between different respiratory viruses. As COVID-19 evolves and immunity levels change, we can expect to see shifts in the prevalence of other respiratory pathogens. Continued wastewater surveillance, like that provided by WastewaterSCAN, will be crucial for tracking these trends and informing public health responses.

Frequently Asked Questions (FAQ)

Is HMPV serious?

For most healthy children, HMPV causes mild illness. However, it can lead to bronchiolitis or croup, requiring medical attention.

How is HMPV spread?

HMPV spreads through contaminated surfaces, the air, and direct contact with infected individuals.

Is there a vaccine for HMPV?

No, there is currently no vaccine available to prevent HMPV infection.

Learn More: For more information on HMPV, visit the CDC website or explore the WastewaterSCAN data dashboard.

Have you or your family been affected by the “barking cough”? Share your experiences in the comments below!

0 comments
0 FacebookTwitterPinterestEmail
Health

Understanding HMPV and easing respiratory struggles

by Chief Editor
written by Chief Editor

Understanding Human Metapneumovirus (HMPV): Risks and Management

Human Metapneumovirus, more commonly referred to as HMPV, is part of the Pneumoviridae family and is known for causing cold-like symptoms. Though mostly mild, it poses significant risks for vulnerable groups such as young children and the elderly. Learn More.

Symptoms and Complications

Most individuals experience symptoms such as sore throat, cough, and congestion. However, severe cases can escalate to bronchiolitis or even pneumonia. See more at CDC.

Advancements in Detection and Diagnosis

Rapid testing technologies like RT-PCR provide quick and accurate diagnosis of HMPV. As research progresses, multiplex PCR panels may offer a more comprehensive approach to identifying co-infections. Research Highlights.

Innovative Diagnostic Tools

The future of respiratory virus diagnostics lies in portable, real-time monitoring devices. These innovations are revolutionizing not only the speed but also the accessibility of diagnosing infections like HMPV.

Preventing the Spread of HMPV

With no specific antiviral treatments or vaccines, prevention is crucial. Simple hygienic practices such as frequent handwashing and avoiding crowded places can mitigate the risk of transmission.

Pro Tips: Enhancing Prevention

Consider using nasal saline solutions and maintaining at least 6 feet distance from infected individuals to reduce virus spread.

Managing Symptoms: Practical Approaches

Over-the-counter medications can alleviate symptoms like cough and fever. Nasal sprays like oxymetazoline offer quick relief from congestion, making them a household staple during viral outbreaks.

Future Trends in Viral Management

The field of antiviral research holds promise. Developing effective therapies capable of targeting viruses like HMPV could transform treatment protocols and significantly reduce the disease burden.

Prophylactic Vaccines on the Horizon

Advances in vaccine technology could soon provide effective prophylaxis against HMPV, similar to recent successes in other respiratory infections.

The Role of Technology in Future Trends

Emerging technologies such as AI-driven predictive modeling and wearable health tech are set to enhance virus detection and management, highlighting a proactive rather than reactive approach to respiratory diseases.

AI-Driven Predictive Models

By analyzing patterns and predicting outbreaks, AI systems can inform public health strategies and resource allocation more effectively than ever before.

Read More about AI in Healthcare –>Explore AI Trends.

Frequently Asked Questions

What Are the Main Symptoms of HMPV?

HMPV symptoms include sore throat, cough, nasal congestion, and fever. In severe cases, lung infections may require medical intervention.

How Can HMPV Be Diagnosed?

Diagnosis primarily involves RT-PCR testing, known for its reliability and speed. Continued research may lead to broader diagnostic panels.

Is there a vaccine available for HMPV?

Currently, no specific vaccine exists for HMPV. Prevention focuses on hygiene and minimizing exposure.

Stay Informed and Engaged

For more insights on viral trends and prevention strategies, subscribe to our newsletter. Join the conversation and share your experiences in the comments below!

0 comments
0 FacebookTwitterPinterestEmail
Health

HMPV is a silent threat to respiratory health

by Chief Editor
written by Chief Editor

The Rising Concern of Human Metapneumovirus (HMPV)

Over recent months, Human Metapneumovirus (HMPV) has drawn significant attention as a public health concern, affecting primarily children and triggering alarms over its potential spread in regions like China, India, and the UK. With flu-like symptoms that resemble other prevalent respiratory viruses, HMPV poses challenges to accurate diagnosis and management.

Historical Context and Current Landscape

Despite being identified over two decades ago, HMPV’s recognition remains lower compared to its viral family members, including the respiratory syncytial virus (RSV) and measles. While many cases have likely occurred throughout the years, largely unreported due to symptom similarities, the recent upsurge signals a pressing need for enhanced vigilance.

New surveillance data shows an increase in hospitalizations due to HMPV, particularly among children. Up to 15% of respiratory illnesses during peak seasons in certain areas have been linked to HMPV, illustrating the virus’s impact despite ongoing diagnostic challenges.

Diagnostic Challenges and Opportunities

Diagnosing HMPV remains challenging primarily due to the similarities it shares with other respiratory illnesses. However, setbacks aren’t all negative, as recent advancements offer a silver lining. For instance, as studies show, PCR testing emerges as the most effective diagnostic tool, although its availability is largely confined to research or specialized settings.

Call for Innovative Solutions

The gap in diagnostic tools emphasizes the urgent need for targeted research and development efforts. As healthcare systems adapt, integrating HMPV testing into standard respiratory illness diagnostic panels could offer profound insights into disease transmission and severity.

Advancements in Vaccine Development

The recent success of RSV vaccines in later stages of clinical trials provides a template for developing a vaccine against HMPV. This effort is fueled by the desire to prevent outbreaks and alleviate the healthcare burden associated with the virus.

Researchers are exploring a variety of vaccine strategies, such as live-attenuated vaccines, subunit vaccines, and viral vector-based platforms, though various hurdles, such as understanding the virus’s impact on immune systems and ensuring risk populations’ safety, must be addressed first.

Collaborative Efforts for Vaccine Development

Collaboration among governments, universities, and pharmaceutical companies is critical in accelerating vaccine and therapeutic development against HMPV. Leveraging lessons learned from the Covid-19 pandemic, such as rapid vaccine production and global monitoring, could be pivotal in tackling new viral threats.

Public Health Measures and Education

Urgent public health measures include regular handwashing, avoiding close contact with symptomatic persons, disinfecting commonly touched surfaces, and mask-wearing in crowded places. Educating health professionals and the public about HMPV is crucial for awareness and prevention.

Building Preparedness for Future Epidemics

As history demonstrates, viruses recognize no borders, which necessitates preparedness and cohesive action across global health systems. Investing in better surveillance tools and public health infrastructure can build resilience against HMPV and similar threats.

FAQs: Navigating the Challenges of HMPV

What are the common symptoms of HMPV?

HMPV symptoms include cough, stuffy nose, fever, swelling, and shortness of breath. Severe cases can lead to bronchitis, pneumonia, and exacerbations of conditions like asthma.

Is there a vaccine for HMPV?

Currently, there is no vaccine available for HMPV, but research in vaccine development is ongoing.

How is HMPV transmitted?

HMPV primarily spreads through breathing droplets, surface contact, and close proximity to infected individuals, often peaking in late winter and early spring.

Engaging Readers for the Future

Did you know? The lessons learned from battling the SARS-CoV-2 coronavirus can be applied to address emerging threats like HMPV, enhancing global preparedness.

Pro tip: Regularly update your knowledge on viral diseases and public health guidelines to stay informed and protected.

For more insights on public health and virology, explore additional articles on our platform or consider subscribing to our newsletter for the latest updates.

0 comments
0 FacebookTwitterPinterestEmail
Health

Banjarmasin braces for Human Metapneumovirus (HMPV) Spread: Dinkes proactive measures in anticipation

by Chief Editor
written by Chief Editor

Human Metapneumovirus (HMPV) Spread Sparks Global Concern, Indonesia on Alert

BANJARMASIN, Indonesia – The Human Metapneumovirus (HMPV), a virus that targets the respiratory system, has entered the global spotlight following outbreaks in several countries, including China and the United States. Its presence has also been detected in Malaysia, and there are reports of its existence in Indonesia.

Although not classified as a deadly disease, HMPV’s potential spread is a cause for concern. Mathematics, a deputy speaker of the Banjarmasin City Council (DPRD), has urged the local Health Agency (Dinkes) to take preventative measures to avoid its spread in the ‘city of a thousand rivers’. "We can’t afford to take this lightly. Even without confirmed cases, early vigilance is crucial," he stressed. "Educating the public about prevention methods is also key."

Banjarmasin’s Dinkes has been tasked with ensuring the readiness of healthcare facilities to detect potential cases. Emma Ariesnawati, head of the Prevention and Control of Disease Division at Dinkes Banjarmasin, revealed that they are continuously monitoring the virus’s potential spread through reports from healthcare facilities like puskesmas and hospitals. This monitoring includes cases related to Acute Respiratory Infection (ARI), pneumonia, and Influenza-Like Illness (ILI).

"Following the Ministry of Health’s directive, we have heightened our vigilance at the puskesmas and hospital levels to anticipate potential HMPV cases," Emma confirmed. She assured that Banjarmasin’s healthcare facilities are equipped to handle HMPV cases, drawing on their experience with Covid-19. "HMPV symptoms mirror those of the common flu, and our facilities have sufficient experience in managing such cases."

While Banjarmasin doesn’t have a dedicated lab for HMPV detection, Dinkes has partnered with the Banjarbaru Public Health Laboratory (BBLabkesmas) for testing suspected samples. They are also actively engaging in health education through puskesmas health promotion teams and health working groups. Information on symptoms, prevention, and the importance of a healthy lifestyle is being directly shared with the public.

"Our goal is to increase public awareness to protect themselves and their families from HMPV infection," Emma stated. She urged the public not to panic, maintain a healthy lifestyle, and follow prevention measures, such as adequate rest, regular handwashing, mask-wearing when unwell, and immediate healthcare consultation if suspicious symptoms appear.

Gejala HMPV mirip dengan flu biasa, seperti batuk, demam, pilek, dan sesak napas. Oleh karena itu, Emma mengingatkan masyarakat untuk tetap menerapkan kebiasaan 3M: memakai masker, mencuci tangan, dan menjaga jarak. “Dengan disiplin, kita bisa menghadapi potensi penyebaran virus ini dengan baik,” imbuhnya.

Pengawasan terhadap pendatang dari daerah terjangkit juga menjadi perhatian serius. Balai Karantina Kesehatan (BKK) di pintu masuk seperti bandara telah menjalankan pengawasan ketat. “Jika ditemukan kasus mencurigakan, BKK akan menginformasikan Dinkes Banjarmasin untuk tindak lanjut,” tandasnya.

0 comments
0 FacebookTwitterPinterestEmail
Health

Chairman of FKKMK UGM Dismisses HMPV Pandemic Potential

by Chief Editor
written by Chief Editor

HMPV: Not Likely to Become the Next Global Pandemic, Says UGM Expert

Health & Wellness

YOGYAKARTA, Indonesia — Professor Tri Wibawa, Dean of the Faculty of Medicine, Public Health, and Nursing at Universitas Gadjah Mada (UGM), has reassured the public that Human Metapneumovirus (HMPV) is unlikely to cause the next global pandemic.

"HMPV has a much lower risk of becoming fatal compared to SARS-CoV-2, and it’s less likely to cause a pandemic," Professor Tri said in an interview in Yogyakarta on Thursday.

Unlike SARS-CoV-2, which can affect people of all ages, HMPV primarily targets children and those with weakened immune systems. "HMPV has been circulating worldwide for a long time and is believed to have infected everyone in their childhood," Tri explained.

First identified in 2001, HMPV is now confirmed to be a known strain by Chinese authorities. While it shares some similarities with SARS-CoV-2, causing respiratory symptoms such as coughing, sneezing, and sore throat, it’s less virulent.

Professor Tri warns that while HMPV is common, certain groups are more at risk: children, the elderly (over 65), and those with lung conditions. He advises maintaining good health habits — eating well, staying hydrated, and getting enough rest — to boost immunity.

Regular handwashing, wearing a mask if you have respiratory symptoms, and avoiding close contact with those who might be infected are crucial. "These measures are important as there’s still no vaccine for HMPV," Tri said.

In conclusion, although HMPV is similar to influenza, it’s not expected to cause a global pandemic. However, everyone should remain vigilant and practice good hygiene to protect themselves from potential infections.

0 comments
0 FacebookTwitterPinterestEmail
Health

How Long Does It Take to Recover from HMPV in Indonesia?

by Chief Editor
written by Chief Editor

Human Metapneumovirus in Indonesia: Familiar, Not New, and Not Highly Dangerous

Jakarta – A viral spotlight in China, the Human Metapneumovirus (HMPV) has been a resident of Indonesia for much longer than anticipated. All cases identified in Indonesia have involved children, but the public is urged not to panic. The virus has been known since 2001 and shares similarities with the common flu.

Minister of Health Budi Gunadi Sadikin reassured the public that HMPV is not a new virus and is not particularly deadly. However, it can lead to severe symptoms in high-risk individuals, such as children, the elderly, and those with weakened immune systems or chronic conditions like diabetes, lung diseases, or heart conditions.

HMPV: Symptoms, Transmission, and Recovery

Epidemiologist Dicky Budiman from Griffith University Australia shed light on HMPV’s transmission and recovery process. The virus spreads through coughing, sneezing, close contact, or touching surfaces contaminated by an infected person. Its incubation period ranges from three to six days.

In most cases, those infected by HMPV can recover unaided without specific treatment. Recovery typically takes between three to seven days, although this duration depends on an individual’s immunity. Currently, there’s no HMPV-specific vaccine or cure available. However, supportive care like rehydration, fever control, and rest can help alleviate symptoms.

Prevention and Protection

Pulmonary specialist Dr. Fathiyah Isbaniah emphasizes preventive measures to avoid HMPV infection. Using masks, especially when unwell, is crucial. Maintaining personal hygiene and a healthy lifestyle also plays a significant role in prevention.

"Definitely, for all viruses, it’s best to use masks. Don’t panic. If you’re sick, stay home, use a mask, and consult a doctor immediately," advises Dr. Fathiyah. "Continue practicing proper handwashing, especially if you’re not feeling well or have the flu, and use a mask or simply stay home."

Stay informed and vigilant, but remember, HMPV is not a new threat, and preventive measures we already practice can help protect us.

0 comments
0 FacebookTwitterPinterestEmail
Health

Jakarta Urges Residents: Stay Calm, HMPV Isn’t Like COVID-19

by Chief Editor
written by Chief Editor

Headline: Dinkes Jakarta Eases Concerns: Pneumonia Wave as Winter Approaches"</p>”>Human Metapneumovirus (HMPV) Not New, Not Like COVID-19

Subhead: Health officials reassure public, urge caution and hygiene as virus cases rise

Article:

The Jakarta Dinas Kesehatan (Health Agency) has clarified that the recent surge in respiratory infections is not due to a new virus, but rather an already known pathogen: Human Metapneumovirus (HMPV). The agency has urged the public not to panic, emphasizing that the virus, which causes acute respiratory infections (ARIs), has been present in the medical world since 2001.

Kepala Dinas Kesehatan Provinsi Jakarta, Ani Ruspitawati, emphasized that HMPV is one of many microorganisms that cause ARIs, affecting both the upper and lower respiratory tracts. She clarified that unlike COVID-19, which was first identified in 2020, HMPV is not a new virus.

The agency has reported a rise in ARI and pneumonia cases since November 2024, a trend that occurs annually at the end of the year. As of now, HMPV has been detected in 19 cases in 2022, 78 cases by October 2023, and 100 cases in 2024.

Symptoms of ARIs caused by HMPV and other viruses include coughing, fever, nasal congestion, and shortness of breath. Infections in the lower respiratory tract can lead to bronchitis, pneumonia, or lung inflammation. Other viruses currently circulating and causing ARIs include influenza A and B, adenovirus, coronavirus, and rhinovirus.

To prevent the spread of the virus, the agency recommends maintaining a healthy lifestyle, practicing good hygiene, and using cough etiquette. While the majority of HMPV cases do not result in severe illness, the virus can be more dangerous for vulnerable populations such as children, the elderly, and those with compromised immune systems.

The agency has also reassured the public that they are prepared to handle ARI cases and are working to strengthen their surveillance system for potential outbreaks. They encourage the public to stay calm but vigilant, and to follow preventative measures to boost their immune system and overall health.

Internal Links:

External Link:

Call to Action:

  • Read More to learn more about the agency’s plans to strengthen their surveillance system and prevent the spread of ARIs.
0 comments
0 FacebookTwitterPinterestEmail
Health

Flu-Like Symptoms: IDI’s Guide to Tackling Them

by Chief Editor
written by Chief Editor

Human Metapneumovirus (HMPV): Understanding the Virus and Its Symptoms

The Indonesian Doctor’s Association (PB IDI) has provided clarification regarding the symptoms and signs of Human Metapneumovirus (HMPV), a virus that has recently garnered public attention. Discovered initially in the Netherlands in 2001, HMPV shares similar symptoms with the common flu.

According to Dr. Erlina Burhan, head of the COVID-19 Task Force at PB IDI, "The acute respiratory infection caused by the Human Metapneumovirus virus has symptoms similar to flu and is usually mild if not absent." She further explained that the incubation period for HMPV ranges between 3 to 6 days, with symptoms lasting approximately 5 days, although this can vary depending on individual immune conditions.

In Indonesia, HMPV is more likely to affect children, presenting with mild symptoms such as coughing and sneezing. The virus is transmitted via droplets from infected individuals and can be prevented through good hygiene practices, avoiding contact with those experiencing flu-like symptoms, and disinfecting potential contaminated items.

Dr. Erlina emphasizes the importance of rest for managing HMPV. "The first step in management, if diagnosed or suspected to be Human Metapneumovirus, is to rest," she advised. Much like the flu, HMPV can resolve on its own. Treatment is supportive, focusing on relieving symptoms such as fever or cough. Currently, there are no specific antiviral drugs or vaccines available for HMPV.

PB IDI recommends the following preventive measures to minimize the risk of HMPV transmission:

  • Maintain good hygiene and a healthy lifestyle
  • Avoid contact with individuals displaying flu symptoms
  • Clean and disinfect potential contaminated items
  • Wear masks, especially for high-risk groups

High-risk groups that should be particularly vigilant include children, the elderly, those with HIV/AIDS, and individuals with chronic illnesses.

Although the symptoms of HMPV are generally mild, society is urged to remain cautious and adhere to basic health protocols to prevent its spread.

0 comments
0 FacebookTwitterPinterestEmail
Health

Emerging HMPV Infections: Jakarta’s silent ISPA wave since 2022

by Chief Editor
written by Chief Editor

Health Alert: HMPV and Influenza A Among Indy Spas Modis (ISPA) Cases in Jakarta

While the current pandemic grabs headlines, it’s important not to forget other respiratory viruses that pose significant risks. Ani, a local health official, reminds citizens to maintain healthy habits to prevent illness and limit virus spread, emphasizing hygienic cough etiquette, regular handwashing, and mask-wearing when unwell.

Ani revealed that Human Metapneumovirus (HMPV) has been causing cases of Indy Spas Modis (ISPA) since 2022 in Jakarta. However, the leading culprits behind the current ISPA outbreak are other viruses, with Influenza A H1N1 pdm2009, Rhinovirus, and Respiratory Syncytial Virus being dominant.

"As of now, our data shows 19 ISPA cases linked to HMPV in 2022, 78 in 2023, and we’ve seen 100 cases this year, 2024," Ani shared. She noted that these figures are continuously updated through coordination with various healthcare facilities and laboratories across Jakarta.

Stay vigilant, and remember, prevention is always the best cure.

0 comments
0 FacebookTwitterPinterestEmail
Newer Posts
Older Posts